Free CME: Identify Factors That Impact Transcatheter Aortic Valve Replacement Outcomes and Cost-Effectiveness. External Inbox

Aloha everyone,

Please see below for this FREE CE on TAVR

Mahalo

The Education Committee

Have a  HAPN Friday!

CLICK HERE TO START NOW

Costs and Clinical Outcomes With Transcatheter Aortic Valve Replacement     Latest Data From Clinical Trials and Real-World Experience   Severe symptomatic aortic stenosis demands urgent care. But which approach is best for a given patient? Three experts share their insights in a video webinar, “TAVR: Optimizing Resource Utilization in the Management of Patients With Aortic Stenosis”. Earn 1.00 / AMA PRA Category 1 Credit™, or 1.00 / ANCC Contact Hours for Nurses. Please click here to begin your participation on myCME. Drs. Amin, Baron, and Galper explore the clinical pathways and health economics of transcatheter aortic valve replacement, or TAVR, including the impact of treatment delays in this vulnerable population.  Begin Activity ►    FACULTY   Sameer Amin, MD Regional Chief Medical Officer of West Region CareMore Health Rancho Palos Verdes, CA     Suzanne J. Baron, MD, MSc Director of Interventional Cardiovascular Research Lahey Hospital & Medical Center Health Outcomes Researcher Beth Israel Deaconess Medical Center Burlington, MA     Benjamin Z. Galper, MD, MPH, FACC Director, Structural Heart Disease Program Inova/Mid-Atlantic Permanente Medical Group McLean, VA   LEARNING OBJECTIVES: After participating in this activity, learners should be better able to: Describe the burden of aortic stenosis (AS) and the importance of timely intervention in patients with severe symptomatic AS Summarize the outcomes and cost-effectiveness data associated with transcatheter aortic valve replacement (TAVR) Identify factors that impact TAVR outcomes and cost-effectiveness Apply best practices for TAVR delivery and patient selection INTENDED AUDIENCE: Members of utilization management teams (eg, physicians, nurses, and administrators) at hospitals, health systems, and health plans who assess whether to authorize TAVR in individual patients.   ACCREDITATION/CREDIT DESIGNATION STATEMENTS In support of improving patient care, Haymarket Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change. PHYSICIANS Haymarket Medical Education designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. NURSES This activity is awarded 1.0 contact hours. (based on 60 minutes per contact hour) DISCLOSURE POLICY AND RESOLUTION OF CONFLICTS OF INTEREST STATEMENT In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Haymarket Medical Education requires that individuals in a position to control the content of an educational activity disclose all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. HME mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational activities.   Accredited by Supported by an educational grant from Edwards Lifesciences